About this app

Lilly Together™ is designed to help you as a
Taltz® (ixekizumab), Olumiant® (baricitinib), or Omvoh™ (mirikizumab-mrkz) user to track your progress.

Please see Indications and Safety Summary including WARNINGS for Olumiant® (baricitinib) at https://www.olumiant.com/?section=isi



When you download and use the Lilly Together™ mobile app, features will be customized based on your treatment plan and may include:

· Plan Setup: Set up your dosing plan, schedule dosing reminders, and track when to take your medication.

· Treatment Map: View your treatment map for a summary of what to expect during your first 6 months of treatment, including treatment touchpoints, recommended dosing, and symptom tracking.

· Dose/Medication Tracking: Log your injections to view if you are staying on track and taking your medication as your Healthcare Provider prescribed.

· Symptom Tracking: Track and monitor your symptoms over time. You can take photos that will not appear in your camera roll to keep all your symptom information in one convenient location.

· Progress: The app puts you in control of tracking your progress, which may help you to have better conversations with your Healthcare provider.

· Logbook Report: Download a logbook report for a 90-day view of your symptom and dosing trends. This may help you understand the progress you're making on treatment so you can share the information with your Healthcare Provider.

· Additional Features: The app also offers Savings Card enrollment for eligible commercially insured patients, the ability to request a free Sharps Disposal container, helpful resources, and one-click-away customer support.

Note: This app is intended for the exclusive use of U.S. residents 18 years of age and older. Lilly Together™ is not intended to provide diagnostic and/or treatment decisions or replace the care and advice of a licensed Healthcare Provider. All medical analysis and treatment plans should be performed by a licensed Healthcare Provider.

Still have questions?
You can call for additional support at 1-844-486-8546.

Lilly Together™ is a trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

Taltz® and its delivery device base are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

Olumiant® is a registered trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

Omvoh™ and its delivery device base are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.


PP-LU-US-0732

New features

The latest version contains medication and tracking support for Omvoh™ (mirikizumab-mrkz):
• Access information about your medication and possible savings
• Log your injections and view plan for upcoming doses
• Log and monitor your symptoms over time in the logbook
• Access a treatment map which allows you to see key steps in your treatment journey
• Create a logbook report that you can save and share outside of the app with your Healthcare Provider

App Permissions

Allows applications to access information about networks.
Allows applications to open network sockets.
Marker permission for applications that wish to access notification policy.
Allows an application to receive the ACTION_BOOT_COMPLETED that is broadcast after the system finishes booting.
Allows read only access to phone state, including the phone number of the device, current cellular network information, the status of any ongoing calls, and a list of any PhoneAccounts registered on the device.
Allows using PowerManager WakeLocks to keep processor from sleeping or screen from dimming.
Allows an app to use fingerprint hardware.